These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16867301)

  • 21. Estimation of individually adapted control parameters for an artificial beta cell.
    Salzsieder E; Albrecht G; Jutzi E; Fischer U
    Biomed Biochim Acta; 1984; 43(5):585-96. PubMed ID: 6383363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A system model of oral glucose absorption: validation on gold standard data.
    Dalla Man C; Camilleri M; Cobelli C
    IEEE Trans Biomed Eng; 2006 Dec; 53(12 Pt 1):2472-8. PubMed ID: 17153204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin pharmacokinetics in insulin-dependent diabetics. Mathematical models].
    Beuscart R; Fontaine P; D'Herbomez-Boidein M
    Diabete Metab; 1989; 15(5):233-41. PubMed ID: 2698365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.
    Fabietti PG; Canonico V; Orsini-Federici M; Sarti E; Massi-Benedetti M
    Diabetes Technol Ther; 2007 Aug; 9(4):327-38. PubMed ID: 17705688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meal simulation model of the glucose-insulin system.
    Dalla Man C; Rizza RA; Cobelli C
    IEEE Trans Biomed Eng; 2007 Oct; 54(10):1740-9. PubMed ID: 17926672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin.
    Caduff A; Talary MS; Mueller M; Dewarrat F; Klisic J; Donath M; Heinemann L; Stahel WA
    Biosens Bioelectron; 2009 May; 24(9):2778-84. PubMed ID: 19286364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness.
    Lopez X; Bouché C; Tatro E; Goldfine AB
    Diabetes Obes Metab; 2009 Feb; 11(2):123-30. PubMed ID: 18518893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
    Rave K; Klein O; Frick AD; Becker RH
    Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
    Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
    Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of insulin and glucose during insulin infusions to diabetes patients. I. Basal regimen].
    Dreval' AV
    Med Tekh; 1982; (6):21-6. PubMed ID: 6759841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.
    Hansen T; Drivsholm T; Urhammer SA; Palacios RT; Vølund A; Borch-Johnsen K; Pedersen O
    Diabetes Care; 2007 Feb; 30(2):257-62. PubMed ID: 17259491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.